US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Conduit Pharmaceuticals Inc.

0.5482

-0.0719-11.59%

Volume:859.17K

Turnover:485.54K

Market Cap:3.65M

PE:-0.03

High:0.6140

Open:0.5948

Low:0.5200

Close:0.6201

Loading ...

Overview Company News Filings

CDT Capital Management Explains Commonsense Violations With the Help of Apple (AAPL) Stock

BDSX Stock Rises After Publication of Study Data for Nodify CDT Test

Biodesix announces publication of new Nodify CDT clinical validation study

Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study

CDT Environmental Technology Reports Decline in 2024 Interim Results Amid PRC Economic Slowdown

CDT Environmental Technology Reports Interim Results; Revenues ~$12.7M For Six Months Ended Jun. 30, Down 18.1% YoY, Net Income ~$1.4M, Down 21.6%

CDT Environmental reports 1H EPS 14c vs. 22c last year

CDT Environmental lowers FY24 revenue view $30.2M-$32.7M from $42.5M-$47M

Press Release: CDT Environmental Technology Reports 2024 Unaudited Interim Financial Results and Provides Business Updates

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

BRIEF-Conduit Pharmaceuticals Partners With Sarborg To Leverage

Conduit Pharmaceuticals to enter agreement with SARBOR

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

THOMSON REUTERS

Conduit Pharmaceuticals Inc - Partners With Sarborg to Leverage AI and Cybernetics

THOMSON REUTERS

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals files to sell 75M shares of common stock for holders

Conduit Pharmaceuticals Receives Japan Patent for Lead Asset AZD1656

MT Newswires Live

BRIEF-Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Conduit Pharmaceuticals Receives Further Patent Approval for Lead Asset Targeting Autoimmune Disorders

THOMSON REUTERS

BRIEF-Conduit Pharmaceuticals Announces Appointment Of Simon Fry To Board Of Directors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CDT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CDT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDT\",,,,,undefined,":{"symbol":"CDT","market":"US","secType":"STK","nameCN":"Conduit Pharmaceuticals Inc.","latestPrice":0.5482,"timestamp":1745263073848,"preClose":0.6201,"halted":0,"volume":859173,"delay":0,"floatShares":5956250,"shares":6662800,"eps":-20.530598,"marketStatus":"Trading","change":-0.0719,"latestTime":"04-21 15:18:26 EDT","open":0.5948,"high":0.614,"low":0.52,"amount":485535.72547578,"amplitude":0.151588,"askPrice":0.556,"askSize":600,"bidPrice":0.55,"bidSize":400,"shortable":0,"etf":0,"ttmEps":-20.530598,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745265600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.6201,"preHourTrading":{"tag":"盘前","latestPrice":0.5975,"preClose":0.6201,"latestTime":"09:29 EDT","volume":21378,"amount":12674.60296326,"timestamp":1745242199007},"postHourTrading":{"tag":"盘后","latestPrice":0.6148,"preClose":0.6201,"latestTime":"19:59 EDT","volume":63320,"amount":39236.3,"timestamp":1744934391638},"volumeRatio":0.095132},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CDT\",,,,,undefined,":{"symbol":"CDT","floatShares":5956250,"roa":"-168.82%","roe":"--","lyrEps":-20.530598,"volumeRatio":0.095132,"shares":6662800,"dividePrice":0,"high":0.614,"amplitude":0.151588,"preClose":0.6201,"low":0.52,"week52Low":0.51,"pbRate":"-0.54","week52High":350,"institutionHeld":0,"latestPrice":0.5482,"committee":-0.2,"eps":-20.530598,"divideRate":0,"volume":859173,"delay":0,"ttmEps":-20.530598,"open":0.5948,"prevYearClose":6.86,"prevWeekClose":0.6201,"prevMonthClose":0.781,"prevQuarterClose":0.781,"fiveDayClose":0.9101,"twentyDayClose":0.8261,"sixtyDayClose":5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CDT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2502142100","title":"CDT Capital Management Explains Commonsense Violations With the Help of Apple (AAPL) Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2502142100","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502142100?lang=en_us&edition=fundamental","pubTime":"2025-01-09 21:10","pubTimestamp":1736428203,"startTime":"0","endTime":"0","summary":"CDT Capital Management, an investment management company, released its annual investor letter. A copy of the letter can be downloaded here. CDT's quantitative risk framework aims to assess whether the stock market is operating rationally. The letter highlighted a potential \"commonsense crisis,\" suggesting that investors may be making irrational decisions. The letter discussed on \"commonsense violations”. The investors’ analysis indicates that the probability of losses is above average, but solely focusing on the numbers can lead to missing important context. They emphasize that violations of commonsense are evident in the data, and before analyzing the math further, it's essential to recognize these underlying issues affecting market behavior. In addition, please check the fund’s top five holdings to know its best picks in 2024.CDT Capital Management stated the following regarding Apple Inc.  in its Q4 2024 investor letter:. Apple Inc.  is in 8th position on our list of 30 Most Popular","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cdt-capital-management-explains-commonsense-131003473.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["USJW.SI","LU1506573853.SGD","LU0061474960.USD","LU0787776722.HKD","AAPL","LU0444971666.USD","SG9999017495.SGD","BK4574","LU2023250504.SGD","IE00BFSS8Q28.SGD","LU1066051811.HKD","IE00BK4W5M84.HKD","IE00B19Z9505.USD","QID","IE00B1XK9C88.USD","LU2125154778.USD","PSQ","NVIW.SI","LU2250418816.HKD","CDT","LU0314104364.USD","LU1291159041.SGD","LU0170899867.USD","LU1803068979.SGD","LU1791710582.SGD","LU0724617625.USD","LU1496350502.SGD","SG9999014542.SGD","QLD","MACW.SI","NQmain","LU2417539215.USD","LU0256863811.USD","LU0444973449.USD",".IXIC","TSYW.SI","LU0082616367.USD","MNQmain","SG9999000418.SGD","LU0784385840.USD","LU0949170772.SGD","TQQQ","USAW.SI","LU1582987597.SGD","LU0661504455.SGD","LU0683600562.USD","LU2552382058.USD","LU0861579265.USD","SQQQ"],"gpt_icon":1},{"id":"2501899727","title":"BDSX Stock Rises After Publication of Study Data for Nodify CDT Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2501899727","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501899727?lang=en_us&edition=fundamental","pubTime":"2025-01-08 20:30","pubTimestamp":1736339400,"startTime":"0","endTime":"0","summary":"Biodesix, Inc. BDSX recently announced anew post-market clinical validation study, publishedinCHEST Pulmonary Journal. The study reaffirms the previously established performance of the BDSX’s Nodify CDTblood-based lung nodule test.The Nodify CDT test is a blood-based diagnostic tool designed to detect cancer-associated autoantibodies, aiding in the identification of lung nodules that may be malignant. It helps healthcare providers prioritize patients for further diagnostic evaluation, potentially reducing unnecessary invasive procedures.Following the announcement, shares of the company moved north 2.7% and closed at $1.49 on Tuesday. In the past year, BDSX’s shares have lost 24.7% compared with the industry’s growth of 3.9%. The S&P 500 has gained 24.4% in the same time frame.The study found that the Nodify CDT test had high specificity, accurately identifying benign lung nodules as low risk, outperforming positron emission tomography  scans, which had more false positives. False posit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bdsx-stock-rises-publication-study-123000579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1989763690.USD","LU1061106388.HKD","BK4566","ABT","BK4196","LU1914381329.SGD","ARAY","LU2764263039.SGD","BK4581","BK4592","LU0234572021.USD","CDT","LU1057294990.SGD","LU1721429741.USD","LU2089984988.USD","LU1691799644.USD","BK4585","MASI","BK4533","LU2468319806.SGD","SG9999002232.USD","IE00B2B36J28.USD","LU0205194284.USD","IE0002141913.USD","LU2237957811.SGD","PET","LU0240878834.USD","SG9999004303.SGD","BK4082","LU2764262908.HKD","LU1023059063.AUD","BK4568","IE00BJT1NW94.SGD","LU2237957902.USD","LU2112291526.USD","SGXZ23171101.USD","BDSX","LU0122379950.USD","BK4192","LU1989763427.SGD","BK4121","LU0868494617.USD","LU0205193047.USD","LU2720916845.USD","BK4588","LU0240877869.USD","SG9999002224.SGD","LU0266013472.USD","IE0009355771.USD","LU0170899867.USD"],"gpt_icon":0},{"id":"2501745132","title":"Biodesix announces publication of new Nodify CDT clinical validation study","url":"https://stock-news.laohu8.com/highlight/detail?id=2501745132","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501745132?lang=en_us&edition=fundamental","pubTime":"2025-01-07 19:11","pubTimestamp":1736248316,"startTime":"0","endTime":"0","summary":"Biodesix (BDSX) announced a new post-market clinical validation study was published in CHEST Pulmonary Journal that reaffirms the previously establ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biodesix-announces-publication-of-new-nodify-cdt-clinical-validation-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biodesix-announces-publication-of-new-nodify-cdt-clinical-validation-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BDSX","BK4121","CDT","BK4196"],"gpt_icon":0},{"id":"2501271615","title":"Biodesix Announces Publication of a New Nodify CDT® Clinical Validation Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2501271615","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501271615?lang=en_us&edition=fundamental","pubTime":"2025-01-07 19:00","pubTimestamp":1736247600,"startTime":"0","endTime":"0","summary":"Analysis of 447 patients receiving the Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal reaffirms test performance. LOUISVILLE, Colo., Jan. 07, 2025  -- Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced a new post-market clinical validation study was published in CHEST Pulmonary Journal that reaffirms the previously established performance of the Nodify CDT blood-based lung nodule test. Clinical data is one of the foundational pillars driving the success of Biodesix through market adoption and payor coverage of its diagnostic tests.“It is very encouraging to see that the performance of the test is robust in further validation studies,” commented Gerard A. Silvestri, MD, MS, Hillenbrand Professor of Thoracic Oncology at the Medical University of South Carolina. “Clinicians often rely on PET scans for risk classification, but this study demonstrates that the performance of PET alone is insufficient for diagnostic d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biodesix-announces-publication-nodify-cdt-110000871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BDSX","BK4121","CDT","BK4192","PET","BK4196"],"gpt_icon":0},{"id":"2494854743","title":"CDT Environmental Technology Reports Decline in 2024 Interim Results Amid PRC Economic Slowdown","url":"https://stock-news.laohu8.com/highlight/detail?id=2494854743","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494854743?lang=en_us&edition=fundamental","pubTime":"2024-12-27 22:27","pubTimestamp":1735309637,"startTime":"0","endTime":"0","summary":"CDT Environmental Technology Investment Holdings Limited ( ($CDTG) ) has provided an update. CDT Environmental Technology Investment Holdings Limit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cdt-environmental-technology-reports-decline-in-2024-interim-results-amid-prc-economic-slowdown?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cdt-environmental-technology-reports-decline-in-2024-interim-results-amid-prc-economic-slowdown?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2494305388","title":"CDT Environmental Technology Reports Interim Results; Revenues ~$12.7M For Six Months Ended Jun. 30, Down 18.1% YoY, Net Income ~$1.4M, Down 21.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494305388","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494305388?lang=en_us&edition=fundamental","pubTime":"2024-12-27 21:40","pubTimestamp":1735306851,"startTime":"0","endTime":"0","summary":"CDT Environmental Technology Reports Interim Results; Revenues ~$12.7M For Six Months Ended Jun. 30, Down 18.1% YoY, Net Income ~$1.4M, Down 21.6%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/12/42700883/cdt-environmental-technology-reports-interim-results-revenues-12-7m-for-six-months-ended-jun-30-dow","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDTG","CDT"],"gpt_icon":0},{"id":"2494007868","title":"CDT Environmental reports 1H EPS 14c vs. 22c last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2494007868","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494007868?lang=en_us&edition=fundamental","pubTime":"2024-12-27 21:35","pubTimestamp":1735306549,"startTime":"0","endTime":"0","summary":"Reports 1H revenue $12.7M vs. $15.5M last year. Yunwu Li, CEO of CDT, said “Amidst the challenging economic and market conditions, our revenue decl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cdt-environmental-reports-1h-eps-14c-vs-22c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cdt-environmental-reports-1h-eps-14c-vs-22c-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDT"],"gpt_icon":0},{"id":"2494718800","title":"CDT Environmental lowers FY24 revenue view $30.2M-$32.7M from $42.5M-$47M","url":"https://stock-news.laohu8.com/highlight/detail?id=2494718800","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494718800?lang=en_us&edition=fundamental","pubTime":"2024-12-27 21:35","pubTimestamp":1735306518,"startTime":"0","endTime":"0","summary":"Based on current visibility, management expects full-year 2024 revenue to be in the range of $30.2 to $32.7 million, with net income in the range o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cdt-environmental-lowers-fy24-revenue-view-30-2m-32-7m-from-42-5m-47m?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cdt-environmental-lowers-fy24-revenue-view-30-2m-32-7m-from-42-5m-47m?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDT"],"gpt_icon":0},{"id":"2494800459","title":"Press Release: CDT Environmental Technology Reports 2024 Unaudited Interim Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2494800459","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494800459?lang=en_us&edition=fundamental","pubTime":"2024-12-27 21:30","pubTimestamp":1735306200,"startTime":"0","endTime":"0","summary":"CDT Environmental Technology Reports 2024 Unaudited Interim Financial Results and Provides Business Updates. Revenue of $12.7 million and earnings per share of $0.14 impacted by reduced project activity due to a slowdown in the PRC economy. SHENZHEN, China, Dec. 27, 2024  -- CDT Environmental Technology Investment Holdings Limited  , a leading provider of waste treatment systems and services throughout China, today reports its unaudited interim financial results for the six months ended June 30, 2024 and provides updates on key business developments and outlook.All amounts are expressed in US dollars unless otherwise stated.-- Revenues decreased by approximately $2.8 million, or 18.1%, to. approximately $12.7 million for the six months ended June 30, 2024 from. approximately $15.5 million for the six months ended June 30, 2023. This. decrease was primarily attributed to ongoing work related to one new. project during the six months ended June 30, 2024, compared to two new. projects in ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDT","CDTG","BK4120"],"gpt_icon":1},{"id":"2493754800","title":"Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2493754800","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493754800?lang=en_us&edition=fundamental","pubTime":"2024-12-23 20:42","pubTimestamp":1734957721,"startTime":"0","endTime":"0","summary":"Shares of Rumble Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/24/12/42644814/why-rumble-shares-are-trading-higher-by-around-43-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLB","USJW.SI","AILE","BK4505","JDZG","SQQQ","BK4121","BK4585","HMC","BK4082","ATXS","BK4555","TQQQ","RELI","TSYW.SI","MNQmain","HSDT","NSANY","APTO","BK4096","NVIW.SI","TPIC","NQmain","BK4179","BK4133","EDBL","ABAT","BK4099","QID","PHIO","BNRG","QLD","USAW.SI",".IXIC","SIGA","CNTM","PSQ","CDT","BK4583","BK4173","ONFO","RUM","BK4023","BK4139","KOD","BK4007","BK4077","BK4141"],"gpt_icon":1},{"id":"2490480061","title":"BRIEF-Conduit Pharmaceuticals Partners With Sarborg To Leverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2490480061","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490480061?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:44","pubTimestamp":1734007469,"startTime":"0","endTime":"0","summary":"BRIEF-Conduit Pharmaceuticals Partners With Sarborg To LeverageDec 12 (Reuters) - Conduit Pharmaceuticals CDT.O:CONDUIT PHARMACEUTICALS TO REVOLUTIONIZE DRUG DEVELOPMENT THROUGH AGREEMENT TO USE ARTIF","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA61BVX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2490807750","title":"Conduit Pharmaceuticals to enter agreement with SARBOR","url":"https://stock-news.laohu8.com/highlight/detail?id=2490807750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490807750?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:35","pubTimestamp":1734006910,"startTime":"0","endTime":"0","summary":"Conduit Pharmaceuticals (CDT) announced that it has entered into an agreement with SARBOR to leverage an advanced artificial intelligence and cyber...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/conduit-pharmaceuticals-to-enter-agreement-with-sarbor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/conduit-pharmaceuticals-to-enter-agreement-with-sarbor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2490807654","title":"Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2490807654","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490807654?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:30","pubTimestamp":1734006600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA61BVX9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2490807131","title":"Conduit Pharmaceuticals Inc - Partners With Sarborg to Leverage AI and Cybernetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2490807131","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490807131?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:30","pubTimestamp":1734006600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nTUA61BVX9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2490005408","title":"Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics","url":"https://stock-news.laohu8.com/highlight/detail?id=2490005408","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490005408?lang=en_us&edition=fundamental","pubTime":"2024-12-12 20:30","pubTimestamp":1734006600,"startTime":"0","endTime":"0","summary":"Conduit Pharmaceuticals partners with SARBORG Limited to leverage artificial intelligence and cybernetics for optimizing key drug development processes, including drug repurposing, discovery, and clinical trial monitoring.This innovative approach aims to reduce human error, cut costs, and improve efficiency, positioning Conduit for success across its current and future portfolio.By entering into this agreement with Sarborg, Conduit will address longstanding challenges in the pharmaceutical sector by seeking to reduce human error in critical decision-making processes including clinical development and asset identification. By integrating Sarborg’s algorithmic AI and cybernetics technology, Conduit aims to enhance efficiency, lower costs, and accelerate timelines by minimizing human intervention, ultimately optimizing the drug development cycle and giving Conduit a significant competitive advantage.“By incorporating Sarborg’s cutting-edge AI and cybernetics platform, Conduit is taking a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/conduit-pharmaceuticals-revolutionize-drug-development-123000853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CDT","BK4121","CDTTW"],"gpt_icon":0},{"id":"2486061158","title":"Conduit Pharmaceuticals files to sell 75M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2486061158","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486061158?lang=en_us&edition=fundamental","pubTime":"2024-11-26 06:20","pubTimestamp":1732573257,"startTime":"0","endTime":"0","summary":"Conduit Pharmaceuticals (NASDAQ:CDT) filed to sell 75,000,000 shares of common stock for holders.\nFiling","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4332646-conduit-pharmaceuticals-files-to-sell-75m-shares-of-common-stock-for-holders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2485962534","title":"Conduit Pharmaceuticals Receives Japan Patent for Lead Asset AZD1656","url":"https://stock-news.laohu8.com/highlight/detail?id=2485962534","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485962534?lang=en_us&edition=fundamental","pubTime":"2024-11-21 21:33","pubTimestamp":1732195990,"startTime":"0","endTime":"0","summary":"Conduit Pharmaceuticals  said Thursday that the Japan Patent Office has approved a composition of matter patent for the company's lead asset, AZD1656, which is a glucokinase activator that targets various autoimmune disorders.The company said the approval follows a recent patent grant in Australia.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7104","CDT.AU","CDT","XAO.AU","XJO.AU","XKO.AU","BK4121"],"gpt_icon":0},{"id":"2485846010","title":"BRIEF-Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2485846010","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485846010?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:33","pubTimestamp":1732192418,"startTime":"0","endTime":"0","summary":"Nov 21 (Reuters) - Conduit Pharmaceuticals Inc   :   * CONDUIT PHARMACEUTICALS RECEIVES FURTHER PATENT APPROVAL FOR LEAD ASSET TARGETING AUTOIMMUNE DISORDERSSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","CDT"],"gpt_icon":0},{"id":"2485973460","title":"Conduit Pharmaceuticals Receives Further Patent Approval for Lead Asset Targeting Autoimmune Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2485973460","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485973460?lang=en_us&edition=fundamental","pubTime":"2024-11-21 20:30","pubTimestamp":1732192239,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nFWN3MS0NO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CDT","BK4121"],"gpt_icon":0},{"id":"2484097629","title":"BRIEF-Conduit Pharmaceuticals Announces Appointment Of Simon Fry To Board Of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2484097629","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484097629?lang=en_us&edition=fundamental","pubTime":"2024-11-20 05:58","pubTimestamp":1732053517,"startTime":"0","endTime":"0","summary":"BRIEF-Conduit Pharmaceuticals Announces Appointment Of Simon Fry To Board Of DirectorsNov 19 (Reuters) - Conduit Pharmaceuticals Inc CDT.O:CONDUIT PHARMACEUTICALS ANNOUNCES APPOINTMENT OF SIMON FRY TO BOARD OF DIRECTORSSource text: ID:nGNX3CFQkTFurther company coverage: CDT.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA7MHBKB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDT","BK4121"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":75,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CDT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-01-27","symbol":"CDT","defaultRemindTime":1737988200000,"type":"split","dateTimestamp":1737954000000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CDT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CDT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CDT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CDT","date":"2025-04-17","current":-0.291968,"percent":0.859944,"low":-460.917103,"twenty":-47.947567,"median":-8.781761,"eighty":-0.581358,"high":-0.0799,"avg":-41.518424,"sd":89.834761,"marketCap":5197615},"quantilePoints":[{"date":"2023-10-13","current":-14.733381,"twenty":-17.829889,"median":-16.48141,"eighty":-15.432593,"marketCap":128180419},{"date":"2023-10-20","current":-14.483663,"twenty":-16.181748,"median":-14.691762,"eighty":-14.550255,"marketCap":126007869},{"date":"2023-10-27","current":-9.739015,"twenty":-15.882086,"median":-14.650142,"eighty":-14.017522,"marketCap":84729429},{"date":"2023-11-03","current":-12.652395,"twenty":-15.199522,"median":-14.483663,"eighty":-12.552508,"marketCap":110075840},{"date":"2023-11-10","current":-10.071973,"twenty":-14.799973,"median":-12.902114,"eighty":-10.821128,"marketCap":87626162},{"date":"2023-11-17","current":-9.745674,"twenty":-14.66679,"median":-12.152959,"eighty":-9.744342,"marketCap":84787364},{"date":"2023-11-24","current":-24.87973,"twenty":-14.683438,"median":-11.487043,"eighty":-9.941453,"marketCap":133977347},{"date":"2023-12-01","current":-63.281053,"twenty":-17.380396,"median":-12.694015,"eighty":-10.221804,"marketCap":340768471},{"date":"2023-12-08","current":-47.866438,"twenty":-32.992686,"median":-14.483663,"eighty":-10.372134,"marketCap":257760767},{"date":"2023-12-15","current":-96.544171,"twenty":-48.488431,"median":-14.650142,"eighty":-10.455207,"marketCap":519890360},{"date":"2023-12-22","current":-67.607963,"twenty":-67.878395,"median":-15.066339,"eighty":-10.588057,"marketCap":364068880},{"date":"2023-12-29","current":-66.255804,"twenty":-68.040654,"median":-16.106832,"eighty":-10.687945,"marketCap":356787502},{"date":"2024-01-05","current":-66.120588,"twenty":-67.716136,"median":-18.728875,"eighty":-10.787832,"marketCap":356059364},{"date":"2024-01-12","current":-60.576735,"twenty":-67.716136,"median":-27.854481,"eighty":-10.887719,"marketCap":326205716},{"date":"2024-01-19","current":-38.130891,"twenty":-67.526833,"median":-37.184379,"eighty":-11.204029,"marketCap":205334848},{"date":"2024-01-26","current":-38.942186,"twenty":-66.82371,"median":-38.942186,"eighty":-11.453747,"marketCap":209703674},{"date":"2024-02-02","current":-35.697004,"twenty":-66.30989,"median":-38.468931,"eighty":-11.886593,"marketCap":192228368},{"date":"2024-02-09","current":-43.742352,"twenty":-66.174674,"median":-38.266107,"eighty":-12.452621,"marketCap":235552565},{"date":"2024-02-16","current":-41.240857,"twenty":-65.71494,"median":-38.468931,"eighty":-12.702339,"marketCap":222082016},{"date":"2024-02-23","current":-38.266107,"twenty":-64.633212,"median":-38.468931,"eighty":-12.868818,"marketCap":206062986},{"date":"2024-03-01","current":-34.750493,"twenty":-63.362183,"median":-38.536539,"eighty":-13.634621,"marketCap":187131404},{"date":"2024-03-08","current":-35.83222,"twenty":-63.226967,"median":-38.198499,"eighty":-14.483663,"marketCap":192956506},{"date":"2024-03-15","current":-42.998664,"twenty":-62.118196,"median":-38.266107,"eighty":-14.550255,"marketCap":231547807},{"date":"2024-03-22","current":-46.649494,"twenty":-58.954144,"median":-38.80697,"eighty":-14.650142,"marketCap":251207527},{"date":"2024-03-28","current":-48.272085,"twenty":-56.303911,"median":-39.212618,"eighty":-14.66679,"marketCap":259945180},{"date":"2024-04-05","current":-44.215608,"twenty":-55.411486,"median":-39.753482,"eighty":-14.799973,"marketCap":238101047},{"date":"2024-04-12","current":-43.13388,"twenty":-54.194543,"median":-40.294346,"eighty":-15.199522,"marketCap":232275945},{"date":"2024-04-19","current":-40.993558,"twenty":-49.732418,"median":-40.835209,"eighty":-15.882086,"marketCap":220750312},{"date":"2024-04-26","current":-427.79731,"twenty":-59.765439,"median":-41.117207,"eighty":-16.930903,"marketCap":228871561},{"date":"2024-05-03","current":-412.617406,"twenty":-65.03886,"median":-41.781721,"eighty":-19.959046,"marketCap":220750312},{"date":"2024-05-10","current":-419.517363,"twenty":-67.256401,"median":-42.187369,"eighty":-24.87973,"marketCap":224441789},{"date":"2024-05-17","current":-89.879435,"twenty":-68.824906,"median":-42.728232,"eighty":-26.06963,"marketCap":217058835},{"date":"2024-05-24","current":-90.49086,"twenty":-78.722712,"median":-42.998664,"eighty":-31.234879,"marketCap":218535426},{"date":"2024-05-31","current":-91.713709,"twenty":-86.822311,"median":-42.998664,"eighty":-32.85747,"marketCap":221488608},{"date":"2024-06-07","current":-85.905174,"twenty":-88.962298,"median":-43.539528,"eighty":-34.750493,"marketCap":207460996},{"date":"2024-06-14","current":-61.753897,"twenty":-87.739448,"median":-43.80996,"eighty":-34.966839,"marketCap":149135662},{"date":"2024-06-21","current":-44.634005,"twenty":-87.066881,"median":-44.080392,"eighty":-35.264314,"marketCap":107791122},{"date":"2024-06-28","current":-31.182661,"twenty":-86.822311,"median":-44.080392,"eighty":-35.020925,"marketCap":75306126},{"date":"2024-07-05","current":-19.568648,"twenty":-86.822311,"median":-43.80996,"eighty":-32.160941,"marketCap":47258285},{"date":"2024-07-12","current":-8.865658,"twenty":-86.822311,"median":-43.336704,"eighty":-24.87973,"marketCap":21410565},{"date":"2024-07-15","current":-8.024949,"twenty":-86.822311,"median":-43.13388,"eighty":-24.87973,"marketCap":19380253},{"date":"2024-08-02","current":-6.267103,"twenty":-86.638884,"median":-43.066272,"eighty":-20.630864,"marketCap":15135054},{"date":"2024-08-09","current":-5.19711,"twenty":-85.477177,"median":-42.998664,"eighty":-16.282943,"marketCap":12551021},{"date":"2024-08-16","current":-2.669983,"twenty":-83.616666,"median":-42.79584,"eighty":-14.799973,"marketCap":15197543},{"date":"2024-08-23","current":-2.782989,"twenty":-82.833276,"median":-42.457801,"eighty":-14.483663,"marketCap":15840775},{"date":"2024-08-30","current":-2.194345,"twenty":-81.616333,"median":-41.849329,"eighty":-12.669043,"marketCap":12490211},{"date":"2024-09-06","current":-2.099892,"twenty":-79.777396,"median":-41.511289,"eighty":-11.403804,"marketCap":11952585},{"date":"2024-09-13","current":-2.329278,"twenty":-74.503975,"median":-40.970425,"eighty":-10.48817,"marketCap":13258248},{"date":"2024-09-20","current":-2.255065,"twenty":-70.177065,"median":-40.294346,"eighty":-9.745674,"marketCap":12835828},{"date":"2024-09-27","current":-2.172418,"twenty":-69.636202,"median":-39.888698,"eighty":-9.018515,"marketCap":12365405},{"date":"2024-10-04","current":-1.66136,"twenty":-68.960122,"median":-39.618266,"eighty":-8.024949,"marketCap":9456462},{"date":"2024-10-11","current":-1.72714,"twenty":-68.284042,"median":-38.942186,"eighty":-5.597593,"marketCap":9830881},{"date":"2024-10-18","current":-1.71196,"twenty":-68.148827,"median":-38.401323,"eighty":-2.782989,"marketCap":9744476},{"date":"2024-10-25","current":-2.062785,"twenty":-67.607963,"median":-38.130891,"eighty":-2.68685,"marketCap":11741374},{"date":"2024-10-31","current":-1.791696,"twenty":-67.49979,"median":-37.590027,"eighty":-2.642322,"marketCap":10198332},{"date":"2024-11-08","current":-1.699632,"twenty":-66.607365,"median":-37.522419,"eighty":-2.434525,"marketCap":9674307},{"date":"2024-11-15","current":-0.683034,"twenty":-66.282847,"median":-37.18438,"eighty":-2.341422,"marketCap":9657424},{"date":"2024-11-22","current":-0.732446,"twenty":-66.147631,"median":-36.711124,"eighty":-2.250005,"marketCap":11097296},{"date":"2024-11-29","current":-0.724301,"twenty":-65.88513,"median":-36.035044,"eighty":-2.191309,"marketCap":10973878},{"date":"2024-12-06","current":-0.642842,"twenty":-65.728158,"median":-35.697004,"eighty":-2.136324,"marketCap":9739703},{"date":"2024-12-13","current":-0.648697,"twenty":-65.557968,"median":-34.885709,"eighty":-2.104952,"marketCap":9828408},{"date":"2024-12-20","current":-0.518958,"twenty":-64.227565,"median":-32.405511,"eighty":-2.070881,"marketCap":7862726},{"date":"2024-12-27","current":-0.460417,"twenty":-63.362183,"median":-30.829231,"eighty":-1.971833,"marketCap":6975772},{"date":"2025-01-03","current":-0.598858,"twenty":-63.25401,"median":-24.87973,"eighty":-1.919522,"marketCap":9073299},{"date":"2025-01-10","current":-0.648697,"twenty":-63.145837,"median":-19.568648,"eighty":-1.895806,"marketCap":9828408},{"date":"2025-01-17","current":-0.583827,"twenty":-61.753897,"median":-17.605142,"eighty":-1.8334,"marketCap":8845567},{"date":"2025-01-24","current":-0.395547,"twenty":-60.812167,"median":-15.982791,"eighty":-1.791603,"marketCap":5992932},{"date":"2025-01-31","current":-0.201729,"twenty":-57.331553,"median":-15.066339,"eighty":-1.741555,"marketCap":3056394},{"date":"2025-02-07","current":-0.122619,"twenty":-55.654875,"median":-14.650142,"eighty":-1.697038,"marketCap":1857808},{"date":"2025-02-14","current":-0.128948,"twenty":-55.330356,"median":-14.483663,"eighty":-1.649553,"marketCap":1953695},{"date":"2025-02-21","current":-0.09414,"twenty":-55.13826,"median":-12.778777,"eighty":-0.882703,"marketCap":1426317},{"date":"2025-02-28","current":-0.088602,"twenty":-53.010523,"median":-12.402677,"eighty":-0.73059,"marketCap":1342416},{"date":"2025-03-07","current":-0.08702,"twenty":-50.521832,"median":-11.403804,"eighty":-0.711674,"marketCap":1318444},{"date":"2025-03-14","current":-0.0799,"twenty":-49.678331,"median":-10.737889,"eighty":-0.666568,"marketCap":1210571},{"date":"2025-03-21","current":-0.211359,"twenty":-49.502551,"median":-10.405763,"eighty":-0.647115,"marketCap":3202300},{"date":"2025-03-28","current":-0.184627,"twenty":-48.933528,"median":-9.908824,"eighty":-0.629809,"marketCap":2797277},{"date":"2025-04-04","current":-0.256525,"twenty":-48.406557,"median":-9.739015,"eighty":-0.621391,"marketCap":4566652},{"date":"2025-04-11","current":-0.400469,"twenty":-48.109826,"median":-8.942087,"eighty":-0.595694,"marketCap":7129147},{"date":"2025-04-17","current":-0.291968,"twenty":-47.947567,"median":-8.781761,"eighty":-0.581358,"marketCap":5197615}],"updateTime":1745255816105}}}